2m 2m 2m 2m 2m 2m 2m
ERASCA (ERAS)
NASDAQ
$17.93-$0.22 (-1.24%)
Price as of Aug 03, 2026 8:20 AM EDT- $6.3BMarket Cap
- 1,205.76%1-Year Change
- BiotechnologyIndustry
ERASCA (ERAS)
$17.93-$0.22 (-1.24%)
ERAS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.15 | ||
Change | -$0.53 (-2.84%) | ||
Open | $18.73 | ||
High | $18.92 | ||
Low | $17.77 | ||
Previous Close | $18.68 | ||
Volume | 2,696,392 | ||
30-Day Average Volume | 4,720,594 | ||
1-Week Change | -5.02% | ||
1-Month Change | -0.93% | ||
1-Year Change | 1,205.76% | ||
3-Year Change | 587.50% | ||
5-Year Change | -13.57% | ||
Fundamentals | |||
Shares Outstanding | 347.1M | ||
Total Assets | $461.2M | ||
Market Cap | $6.3B | ||
Enterprise Value | $6.3B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$183.4M | ||
Free Cash Flow | -$27.4M | ||
EBIT | -$183.4M | ||
EBITDA | -$182.7M | ||
Net Working Capital | $227.1M | ||
EPS | -$0.60 | ||
Enterprise Value/EBITDA | -34 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 16 | ||
P/E | -30 | ||
PEG | 0 | ||
Price/Free Cash Flow | -230 | ||
Price/Operating Cash Flow | -230 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue